Scarica l'app Stockscreener
1.56
3.11%
-0.05
Dopo l'orario di chiusura:
1.53
-0.03
-1.92%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FBIO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.61
Aprire:
$1.63
Volume 24 ore:
319.21K
Relative Volume:
0.78
Capitalizzazione di mercato:
$47.76M
Reddito:
$80.97M
Utile/perdita netta:
$-78.31M
Rapporto P/E:
-0.1407
EPS:
-11.0849
Flusso di cassa netto:
$-129.56M
1 W Prestazione:
-9.30%
1M Prestazione:
-0.64%
6M Prestazione:
+7.96%
1 anno Prestazione:
-22.00%
Intervallo 1D:
$1.47
$1.63
Intervallo di 1 settimana:
$1.47
$1.78
Portata 52W:
$1.355
$2.89
Fortress Biotech Inc Stock (FBIO) Company Profile
Nome
Fortress Biotech Inc
Settore
Industria
Telefono
781-652-4500
Indirizzo
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Confronta FBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
1.56 | 47.76M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-15 | Ripresa | ROTH MKM | Buy |
| 2022-08-04 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-10-02 | Iniziato | The Benchmark Company | Buy |
| 2019-12-18 | Iniziato | B. Riley FBR | Buy |
| 2018-02-28 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | Iniziato | Rodman & Renshaw | Buy |
| 2017-03-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2016-10-03 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Fortress Biotech Inc Borsa (FBIO) Ultime notizie
Fortress Biotech (FBIO) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Fortress Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire
Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan
Fortress Biotech, Inc. (NASDAQ:FBIO) Q4 2024 Earnings Call Transcript - Insider Monkey
Fortress Biotech’s Mixed Earnings Call: Emrosi’s Launch and Challenges - TipRanks
Breakthrough: CKPT Secures FDA Approval and $416M Merger Deal in Transformative Year - Stock Titan
MUSTANG BIO, INC. SEC 10-K Report - TradingView
Journey Medical Reports 2024 Financial Results - TipRanks
FDA Green Light for Journey Medical's Rosacea Drug Reshapes 2024 Performance - StockTitan
Fortress Biotech Inc (FBIO) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus
Fortress Biotech (NASDAQ:FBIOP) Trading Up 3.9% – Here’s Why - Defense World
Fortress Biotech (FBIO) Expected to Announce Earnings on Thursday - Defense World
Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025 - GlobeNewswire
Journey Medical Sets Date for 2024 Annual Results: Dermatology Leader's Financial Update - Stock Titan
Atria Investments Inc Buys 16,841 Shares of Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
Partex And Fortress Biotech Announce Collaboration To Accelerate Biopharma Asset Evaluation - Nasdaq
Fortress Biotech, Partex Team Up for Asset Identification, Evaluation Using AI -March 17, 2025 at 09:36 am EDT - Marketscreener.com
Fortress Biotech partners with Partex for AI-driven drug discovery By Investing.com - Investing.com Australia
Fortress Biotech partners with Partex for AI-driven drug discovery - Investing.com
Partex NV and Fortress Biotech, Inc. Announce Strategic Collaboration to Leverage AI in Biopharmaceutical Drug Discovery - Nasdaq
Partex and Fortress Biotech Announce Strategic - GlobeNewswire
AI Breakthrough: Fortress Biotech's New Partnership Transforms Drug Development Process - StockTitan
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
Equities Analysts Offer Predictions for FBIO Q1 Earnings - Defense World
Fortress Biotech (NASDAQ:FBIO) Receives “Buy” Rating from Roth Mkm - Defense World
Benign Growth For Fortress Biotech, Inc. (NASDAQ:FBIO) Underpins Its Share Price - Simply Wall St
CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma - Longview News-Journal
Lake Street Downgrades Checkpoint Therapeutics to Hold From Buy, $4.10 Price Target - Marketscreener.com
Checkpoint (CKPT) Shares Skyrocket After A Takeover Agreement - Stocks Telegraph
Checkpoint Therapeutics Shares Leap Premarket on Takeover by Sun Pharma -March 10, 2025 at 06:24 am EDT - Marketscreener.com
Sun Pharma Pays 66% Premium in $355M Checkpoint Therapeutics Acquisition - Stock Titan
Checkpoint Therapeutics to Be Acquired by India's Sun Pharmaceutical -March 10, 2025 at 04:50 am EDT - Marketscreener.com
Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher - Mint
Sun Pharma to acquire US based onco-derma firm Checkpoint for $355 mn - Business Standard
Sun Pharma to acquire 100% stake in Nasdaq-listed Checkpoint Therapeutics - Business Standard
India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million - Reuters
India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million -March 09, 2025 at 11:49 pm EDT - Marketscreener.com
Sun Pharma to Acquire Checkpoint Therapeutics - Quantisnow
India’s Sun Pharma to buy Checkpoint Therapeutics for $355 mln By Investing.com - Investing.com Australia
India’s Sun Pharma to buy Checkpoint Therapeutics for $355 mln - Investing.com
Sun Pharma to acquire Checkpoint Therapeutics for Rs 3,000 crore - Business Upturn
Mustang Bio meets Nasdaq’s equity listing requirements By Investing.com - Investing.com South Africa
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - The Manila Times
Fortress Biotech, Inc. (NASDAQ:FBIOP) Short Interest Down 78.3% in February - Defense World
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - GlobeNewswire
Trading (FBIOP) With Integrated Risk Controls - news.stocktradersdaily.com
FDA extends review of Fortress Biotech's CUTX-101 drug - MSN
Is Fortress Biotech Inc (NASDAQ: FBIO) Still Hot This Week? - Stocks Register
(FBIOP) On The My Stocks Page - Stock Traders Daily
Buying Buzz: Fortress Biotech Inc [FBIO] PRESIDENT, CEO & CHAIRMAN ROSENWALD LINDSAY A MD purchases 763,359 shares of the company – Knox Daily - Knox Daily
Fortress Biotech Inc Azioni (FBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.05%
1.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):